NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 3 hours 59 min ago
Funding Opportunity RFA-AI-18-053 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) will support basic science research to address outstanding questions in HIV latency and persistence by leveraging state-of-the-art single-cell multi-omics approaches. The goal is to interrogate HIV persistence with high molecular detail and resolution to better understand HIV persistence at the single-cell level. Emphasis will be on multi-omics or multiplex approaches integrating cutting-edge single-cell analysis technologies.
Notice NOT-OD-19-030 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-064 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2) responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and time-sensitive prescription drug abuse research opportunities (e.g., new state or local efforts); 4) responses to unexpected and time-sensitive medical system issues (e.g. opportunities to understand addiction services in the evolving health care system); and 5) responses to unexpected and time-sensitive criminal or juvenile justice opportunities (e.g. new system and/or structural level changes) that relate to drug abuse and access and provision of health care service. It should be clear that the knowledge gained from the proposed study is time-sensitive and that an expedited rapid review and funding are required in order for the scientific question to be answered (i.e. an imminent policy change will not allow for standard review and funding timeline).
Funding Opportunity RFA-DK-18-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for a Data Coordinating Center (DCC) that will support the Diabetic Foot Consortium (DFC) for clinical research on diabetic foot ulcers. The first studies will validate biomarkers that predict healing or response to therapy and assess infection or recurrence risk. Future research may involve clinical trials and studies on the pathophysiology of diabetic foot ulcers. Given the clinical complexity of diabetic wound healing, the applicant must have experience serving as the DCC on clinical studies of diabetic foot ulcers. The DCC will provide overall project coordination, administration, quality control, data management, and biostatistical support.
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-061 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts aimed towards commercial product development in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports genomics research developing innovative analytical and computational commercial products, methodologies, and approaches, early stage development of commercial tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems.
Notice of Changes to RFA-AG-19-020 "Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)"
Notice NOT-AG-18-038 from the NIH Guide for Grants and Contracts
Addition of SBIR Direct-to-Phase II Program to PAR-18-588, Assistive Technology for Persons with Alzheimers Disease and Related Dementias and Their Caregivers (R43/R44 Clinical Trial Optional)"
Notice NOT-AG-18-042 from the NIH Guide for Grants and Contracts
Notice of Updated Application Forms Package for NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trial Optional)
Notice NOT-EB-18-033 from the NIH Guide for Grants and Contracts
Correction of Due Dates for Letters of Intent for PAR-18-930 Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01)
Notice NOT-MH-18-069 from the NIH Guide for Grants and Contracts
Notice of Clarification to Language for Project Characteristics in PAR-18-549, Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice NOT-NS-19-020 from the NIH Guide for Grants and Contracts
Notice of Clarification to Language for Project Characteristics in PAR-18-550, Analytical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice NOT-NS-19-021 from the NIH Guide for Grants and Contracts
Notice of Expiration of PA-18-474 "Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed)"
Notice NOT-NR-18-023 from the NIH Guide for Grants and Contracts
Notice of Change in Receipt Date for the Emerging Global Leader Award (K43) (Independent Clinical Trial Not Allowed)
Notice NOT-TW-18-009 from the NIH Guide for Grants and Contracts
Notice of NIBIB's participation in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
Notice NOT-EB-18-032 from the NIH Guide for Grants and Contracts
Notice of Correction to Key Dates for RFA-NS-19-003 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)"
Notice NOT-NS-19-019 from the NIH Guide for Grants and Contracts
Notice of Correction to Key Dates for RFA-NS-19-002 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)"
Notice NOT-NS-19-018 from the NIH Guide for Grants and Contracts
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
Funding Opportunity PAR-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports planning, design and initial pilots for locally relevant and catalytic research on non-communicable diseases (NCDs) or injury in low and middle-income countries (LMICs). Research addressing multiple NCDs and their risk factors and research addressing NCDs as comorbidities for/with infectious diseases including HIV/AIDS is encouraged. Scientists in the United States (U.S.) or upper middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Income categories used are defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups. Pilot activities and research are expected to inform the development of more comprehensive research programs that contribute to the long-term goals of building sustainable research capacity in LMICs to address NCDs and injury throughout life and to lead to diagnostics, prevention, treatment and implementation strategies. The proposed work may also contribute to developing a base for research networking and evidence-based policy beyond the specific research project.
Notice of Further Amendment of PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
Notice NOT-CA-19-007 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-029 from the NIH Guide for Grants and Contracts
Notice NOT-MH-18-070 from the NIH Guide for Grants and Contracts
NIH Funding Opportunities
- Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program (U18)
- Notice of Correction to RFA-CA-19-008 "The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed)"
- Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)
- Notice of Removal of Matching Requirement Instructions for RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)"
- Notice of Intent to Publish a Funding Opportunity Announcement for Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)